Envoy Medical Warrant
COCHW
60 hedge funds and large institutions have $2.9M invested in Envoy Medical Warrant in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
5% more funds holding
Funds holding: 57 → 60 (+3)
1% less capital invested
Capital invested by funds: $2.93M → $2.9M (-$36.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$939K |
| 2 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$23.5K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$13.4K |
| 4 |
Jane Street
New York
|
+$9.89K |
| 5 |
Calamos Advisors
Naperville,
Illinois
|
+$4.74K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
Fir Tree Capital Management
New York
|
-$15K |
| 2 |
TCA
Taconic Capital Advisors
New York
|
-$7K |
| 3 |
AGM
Alpine Global Management
New York
|
-$2.37K |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$2K |
| 5 |
TCM
Tegean Capital Management
New York
|
-$2K |
COCHW Hedge Fund Activity: Q4 2022 in Review
60 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q4 2022, worth a combined $2.9M — down 1.3% from $2.93M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new COCHW positions and 5 closed out — a net gain of 3 holders — while 7 added to existing stakes and 4 trimmed.
The largest buyer was BlueCrest Capital Management, adding an estimated $939K. The largest seller was Fir Tree Capital Management, exiting entirely with an estimated $15K sold.
- 60 institutional investors held Envoy Medical Warrant (COCHW) as of Q4 2022, up from 57 in Q3 2022.
- Funds reported $2.9M of Envoy Medical Warrant stock for Q4 2022, down 1.3% quarter-over-quarter.
- 8 funds opened new Envoy Medical Warrant positions in Q4 2022 and 5 closed out, a net change of +3 holders.
- The largest Envoy Medical Warrant buyer in Q4 2022 was BlueCrest Capital Management, an estimated $939K added.
- The largest Envoy Medical Warrant seller in Q4 2022 was Fir Tree Capital Management, an estimated $15K sold.
Based on aggregated 13F filings for Q4 2022.